Fig. 8.

(A) Schematic of the preparation of DG@Gel. (i) Change in the pH of DG@Gel over 24 ​h in different glucose concentrations. (ii) Photographs of wound tissues treated with different sample groups on days 0, 3, 7, and 14, and wound healing boundaries in different treatment groups in vivo (Reproduced with permission of Ref. [144]). (B) Schematic illustration of preparing procedure of Cu@ZIF and Cu@ZIF/GOx. (iii) Antibacterial efficacy of Cu@ZIF/GOx treated with different concentration of glucose after 6 ​h incubation (Reproduced with permission of Ref. [148]). (C) Schematic illustration of the synthetic route of GOx-HMSN-AZM. (v) He glucose concentration variation under the catalyst of 200 ​μg/mL GOx-HMSN-AZM on different reaction times. (vi) The concentration of generated H₂O₂ catalyzed by 200 ​μg/mL GOx-HMSN-AZM on different reaction times. (vii) Photographs of bacterial colonies formed by S. aureus in biofilms which were treated with 500 ​μg/mL of PBS, HMSN, HMSN-AZM, GOx-HMSN and GOx-HMSN-AZM (Reproduced with permission of Ref. [149]).